Chemoradiotherapy effcacy in squamous cell rectal cancer: a propensity score matched analysis
Introduction. Sporadic cases of squamous cell carcinoma of the rectum (rSCC) do not allow a comparative characterization of tumor aggressiveness and its response to chemoradiotherapy in relation to more common squamous cell entities, in particular, anal squamous cell carcinoma (aSCC). Objective: com...
Saved in:
| Main Authors: | V. V. Murzo, S. S. Gordeev, V. S. Myshlyakov, Z. Z. Mamedli |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2023-09-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/2673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgery, chemoradiotherapy, or chemoradiation plus immunotherapy: Treatment strategies for nonmetastatic anal squamous cell carcinoma
by: Fang He, et al.
Published: (2024-12-01) -
Prognosis Prediction and Surgical Benefit Subgroup Analysis in Anal Squamous Cell Carcinoma Patients Undergoing Concurrent Chemoradiotherapy
by: Quan Wang, et al.
Published: (2025-08-01) -
Immediate and long-term results of radiation therapy in combination with capecitabine and oxaliplatin in the treatment of patients with asquamous cell carcinoma of the anus
by: A. A. Nevolskikh, et al.
Published: (2023-09-01) -
Development and validation a radiomics combined clinical model predicts treatment response for esophageal squamous cell carcinoma patients
by: Xiaoyan Yin, et al.
Published: (2025-04-01) -
The role of chemoradiotherapy in the treatment of neuroendocrine rectal cancer: case reports
by: S. S. Gordeev, et al.
Published: (2022-09-01)